Lipofundin Mct/Lct

Soybean oil, the active ingredient in Lipofundin Mct/Lct, is a parenteral nutrition lipid emulsion presented as an intravenous lipid emulsion for intravenous use. It supplies calories and essential fatty acids to patients who cannot receive enteral feeding, supporting energy needs and membrane phospholipid synthesis.

GNH USA supplies Lipofundin Mct/Lct as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and reliable cold‑chain logistics for clinical parenteral nutrition products.

Lipofundin Mct/Lct is a parenteral nutrition lipid emulsion used to provide caloric and essential fatty acid support.

Enteral feeding intolerance: supplies calories and essential fatty acids when oral or tube feeding is not possible. Post‑operative recovery: provides supplemental energy and fatty acids to support healing after surgery. Critical illness or severe malnutrition: delivers necessary lipids for patients in intensive care or with profound nutritional deficits.

Lipofundin Mct/Lct may cause a range of infusion‑related reactions.

Common Side Effects: - Hypertriglyceridaemia: elevated serum triglyceride levels. - Fever or chills during infusion. - Infusion site erythema or pain. - Nausea or mild gastrointestinal discomfort. - Headache. - Transient increase in liver enzymes.

Serious or Rare Side Effects: - Fat overload syndrome: respiratory distress, hepatomegaly, coagulopathy. - Anaphylactic or severe allergic reaction. - Pulmonary embolism from lipid particles. - Severe hepatic dysfunction or steatosis. - Thrombocytopenia. - Increased risk of infection due to lipid‑rich medium.

When using Lipofundin Mct/Lct, clinicians should follow key safety measures.

Assess triglyceride levels: monitor serum triglycerides before and during therapy. Check for allergies: avoid in patients with known soybean or egg allergy. Use aseptic technique: ensure sterile handling to prevent contamination. Monitor for signs of fat overload: watch for respiratory distress, fever, hepatomegaly. Avoid concomitant lipid‑containing infusions: prevent excess lipid load. Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lipofundin Mct/Lct can interact with several medications affecting lipid metabolism.

Major Interactions (Avoid): - Propofol: additive lipid load may cause severe hypertriglyceridaemia. - Corticosteroids: increase serum triglyceride concentrations. - Heparin: may potentiate hypertriglyceridaemia.

Moderate Interactions (Monitor Closely): - Cyclosporine: may raise lipid levels. - Estrogen therapy: can elevate triglycerides. - Concurrent parenteral nutrition containing other lipids: risk of excess calories and lipid overload.